Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
Insulin receptor substrate 2 (IRS2) is a key downstream mediator of insulin and insulin-like growth factor 1 (IGF1) signalling pathways and plays a major role in liver metabolism. The aim of this study was to investigate whether IRS2 had an impact on the hepatic fibrotic process associated with chol...
Main Authors: | Andrea Villar-Lorenzo, Patricia Rada, Esther Rey, Patricia Marañón, Ana I. Arroba, Beatriz Santamaría, Jorge Sáiz, Francisco J. Rupérez, Coral Barbas, Carmelo García-Monzón, Ángela M. Valverde, Águeda González-Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2019-07-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/12/7/dmm038810 |
Similar Items
-
The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
by: Takahiro Nishio, et al.
Published: (2022-10-01) -
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
by: Qingmiao Shi, et al.
Published: (2023-05-01) -
Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
by: Huiling Cao, et al.
Published: (2024-01-01) -
JCAD, a new potential therapeutic target in cholestatic liver disease
by: Byoung Kuk Jang
Published: (2024-04-01) -
Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease
by: Juan Hao, et al.
Published: (2023-07-01)